Status:
COMPLETED
Study of Tumor Samples From Patients With Ependymoma Treated on the Children's Oncology Group ACNS0121 Trial
Lead Sponsor:
Children's Oncology Group
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Childhood Infratentorial Ependymoma
Childhood Supratentorial Ependymoma
Eligibility:
All Genders
1-21 years
Brief Summary
This research trial studies tumor samples from patients with ependymoma treated on the Children Oncology Group ACNS0121 trial. Studying samples of tumor tissue from patients with cancer in the laborat...
Detailed Description
PRIMARY OBJECTIVES: I. To examine the prognostic role of histopathological variables, in particular cellular density, mitotic count, and tumor cell invasion in intracranial pediatric ependymomas. II...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Diagnosed with ependymoma and treated on COG-ACNS0121
- Previously collected tumor samples banked at the Children Oncology Group BioPathology
Exclusion
Key Trial Info
Start Date :
March 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 1 2013
Estimated Enrollment :
80 Patients enrolled
Trial Details
Trial ID
NCT01407744
Start Date
March 1 2012
End Date
April 1 2013
Last Update
May 18 2016
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Children's Oncology Group
Monrovia, California, United States, 91006-3776